Cargando…
Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens
AIMS: Persistent infection indicated by detection of human papillomavirus 16 (HPV-16) on repeat testing over a period of time poses the greatest cervical cancer risk. However, variants of HPV-16, HPV-31 and HPV-33 may share several short sequence homologies in the hypervariable L1 gene commonly targ...
Autores principales: | Lee, Sin Hang, Vigliotti, Veronica S, Pappu, Suri |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921263/ https://www.ncbi.nlm.nih.gov/pubmed/19858529 http://dx.doi.org/10.1136/jcp.2009.069401 |
Ejemplares similares
-
Validation of human papillomavirus genotyping by signature DNA sequence analysis
por: Lee, Sin Hang, et al.
Publicado: (2009) -
Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen
por: Lee, Sin Hang, et al.
Publicado: (2009) -
Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories
por: Lee, Sin Hang, et al.
Publicado: (2007) -
From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice
por: Lee, Sin Hang, et al.
Publicado: (2014) -
Genetic Variation of Human Papillomavirus Type 16 in Individual Clinical Specimens Revealed by Deep Sequencing
por: Kukimoto, Iwao, et al.
Publicado: (2013)